TLR2/6 agonists and interferon-gamma induce human melanoma cells to produce CXCL10

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

(2013) Omid Hamid et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nivolumab plus Ipilimumab in Advanced Melanoma

(2013) Jedd D. Wolchok et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adoptive T-Cell Therapy Using Autologous Tumor-Infiltrating Lymphocytes for Metastatic Melanoma

(2012) Richard Wu et al.   CANCER JOURNAL

Role of Chemokines and Chemokine Receptors in Shaping the Effector Phase of the Antitumor Immune Response

(2012) K. Franciszkiewicz et al.   CANCER RESEARCH

PD-1 Blockade Enhances T-cell Migration to Tumors by Elevating IFN-  Inducible Chemokines

(2012) W. Peng et al.   CANCER RESEARCH

NF- B Hyperactivation in Tumor Tissues Allows Tumor-Selective Reprogramming of the Chemokine Microenvironment to Enhance the Recruitment of Cytolytic T Effector Cells

(2012) R. Muthuswamy et al.   CANCER RESEARCH

Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma

(2012) G. Erdag et al.   CANCER RESEARCH

Adoptive Immunotherapy of Advanced Melanoma

(2012) Ronnie Shapira-Frommer et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

(2012) Suzanne L. Topalian et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tumor-Infiltrating Lymphocytes in Melanoma

(2012) Sylvia Lee et al.   Current Oncology Reports

Structural Biology of the Toll-Like Receptor Family

(2011) Jin Young Kang et al.   Annual Review of Biochemistry

Chemotherapy Induces Intratumoral Expression of Chemokines in Cutaneous Melanoma, Favoring T-cell Infiltration and Tumor Control

(2011) M. Hong et al.   CANCER RESEARCH

Molecular Insights on the Peripheral and Intratumoral Effects of Systemic High-Dose rIL-2 (Aldesleukin) Administration for the Treatment of Metastatic Melanoma

(2011) G. R. Weiss et al.   CLINICAL CANCER RESEARCH

The role of melanoma tumor-derived nitric oxide in the tumor inflammatory microenvironment: Its impact on the chemokine expression profile, including suppression of CXCL10

(2011) Keiji Tanese et al.   INTERNATIONAL JOURNAL OF CANCER

Interferons Induce CXCR3-cognate Chemokine Production by Human Metastatic Melanoma

(2010) Lynn T. Dengel et al.   JOURNAL OF IMMUNOTHERAPY

Immunotherapy for Melanoma: Current Status and Perspectives

(2010) Doru T. Alexandrescu et al.   JOURNAL OF IMMUNOTHERAPY

Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment

(2009) H. Harlin et al.   CANCER RESEARCH

Differential expression of immunoregulatory genes in monocytes in response toPorphyromonas gingivalisandEscherichia colilipopolysaccharide

(2009) H. E. Barksby et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Cultured human melanocytes express functional Toll-like receptors 2–4, 7 and 9

(2009) Ning Yu et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells

(2009) S. M. Makela et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Intracutaneous injection of the macrophage-activating lipopeptide-2 (MALP-2) which accelerates wound healing in mice - a phase I trial in 12 patients

(2008) Margarete Niebuhr et al.   EXPERIMENTAL DERMATOLOGY

Activation of toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors

(2008) Y. Goto et al.   MOLECULAR CANCER THERAPEUTICS